231 related articles for article (PubMed ID: 19107118)
21. Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB.
Uchida Y; Houben E; Park K; Douangpanya S; Lee YM; Wu BX; Hannun YA; Radin NS; Elias PM; Holleran WM
J Invest Dermatol; 2010 Oct; 130(10):2472-80. PubMed ID: 20520628
[TBL] [Abstract][Full Text] [Related]
22. Acute activation of acid ceramidase affects cytokine-induced cytotoxicity in rat islet beta-cells.
Zhu Q; Shan X; Miao H; Lu Y; Xu J; You N; Liu C; Liao DF; Jin J
FEBS Lett; 2009 Jun; 583(12):2136-41. PubMed ID: 19497324
[TBL] [Abstract][Full Text] [Related]
23. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
Dai Y; Liu M; Tang W; DeSano J; Burstein E; Davis M; Pienta K; Lawrence T; Xu L
Clin Cancer Res; 2008 Dec; 14(23):7701-10. PubMed ID: 19047096
[TBL] [Abstract][Full Text] [Related]
24. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
25. Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.
Cho SM; Kwon HJ
Arch Pharm Res; 2019 Mar; 42(3):232-243. PubMed ID: 30661200
[TBL] [Abstract][Full Text] [Related]
26. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy.
Saad AF; Meacham WD; Bai A; Anelli V; Elojeimy S; Mahdy AE; Turner LS; Cheng J; Bielawska A; Bielawski J; Keane TE; Obeid LM; Hannun YA; Norris JS; Liu X
Cancer Biol Ther; 2007 Sep; 6(9):1455-60. PubMed ID: 17881906
[TBL] [Abstract][Full Text] [Related]
27. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
28. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
[TBL] [Abstract][Full Text] [Related]
29. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
Pchejetski D; Doumerc N; Golzio M; Naymark M; Teissié J; Kohama T; Waxman J; Malavaud B; Cuvillier O
Mol Cancer Ther; 2008 Jul; 7(7):1836-45. PubMed ID: 18644996
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
[TBL] [Abstract][Full Text] [Related]
31. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.
Tani M; Igarashi Y; Ito M
J Biol Chem; 2005 Nov; 280(44):36592-600. PubMed ID: 16126722
[TBL] [Abstract][Full Text] [Related]
32. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
33. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer.
Kim KW; Hwang M; Moretti L; Jaboin JJ; Cha YI; Lu B
Autophagy; 2008 Jul; 4(5):659-68. PubMed ID: 18424912
[TBL] [Abstract][Full Text] [Related]
34. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C; Obeid LM
Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
[TBL] [Abstract][Full Text] [Related]
35. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
36. Identification of cystatin SA as a novel inhibitor of acid ceramidase.
Eliyahu E; Shtraizent N; He X; Chen D; Shalgi R; Schuchman EH
J Biol Chem; 2011 Oct; 286(41):35624-35633. PubMed ID: 21846728
[TBL] [Abstract][Full Text] [Related]
37. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
38. Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.
Masood R; Roy I; Zu S; Hochstim C; Yong KT; Law WC; Ding H; Sinha UK; Prasad PN
Integr Biol (Camb); 2012 Feb; 4(2):132-41. PubMed ID: 22159374
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
Aoyama Y; Sobue S; Mizutani N; Inoue C; Kawamoto Y; Nishizawa Y; Ichihara M; Kyogashima M; Suzuki M; Nozawa Y; Murate T
Biochem Biophys Res Commun; 2017 Apr; 486(2):551-557. PubMed ID: 28322796
[TBL] [Abstract][Full Text] [Related]
40. Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats.
Nahas Z; Jiang Y; Zeidan YH; Bielawska A; Szulc Z; Devane L; Kalivas P; Hannun YA
Behav Brain Res; 2009 Jan; 197(1):41-4. PubMed ID: 18768150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]